Pharmaceutical companies in the U.S have marketed SSRI antidepressants as medications that correct an imbalance in brain chemistry. These ads often describe depression as being caused by low levels of serotinin and other chemicals in the brain. Science has repeatedly failed to find such an imbalance.

Read the Article: Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature